Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

March 2017 - FRMC

Department

News Connection
03/20/2017
The Association for Accessible Medicines’ Biosimilars Council filed a brief contesting a decision allowing biologic manufacturers market exclusivity beyond 12 years. 
The Association for Accessible Medicines’ Biosimilars Council filed a brief contesting a decision allowing biologic manufacturers market exclusivity beyond 12 years. 
The Association for Accessible...
03/20/2017
First Report Managed Care
News Connection
03/20/2017
A final rule by the Department of Health and Human Services (HHS) that establishes several cardiac and orthopedic bundled-payment models under Medicare was recently delayed; however, recent reports clarified that the launch date of the...
A final rule by the Department of Health and Human Services (HHS) that establishes several cardiac and orthopedic bundled-payment models under Medicare was recently delayed; however, recent reports clarified that the launch date of the...
A final rule by the Department...
03/20/2017
First Report Managed Care
News Connection
03/20/2017
A recent rule proposed by the Centers for Medicare & Medicaid Services (CMS) intends to stabilize the Affordable Care Act (ACA) individual and small group insurance markets by expanding pre-enrollment verification, providing more flexibility...
A recent rule proposed by the Centers for Medicare & Medicaid Services (CMS) intends to stabilize the Affordable Care Act (ACA) individual and small group insurance markets by expanding pre-enrollment verification, providing more flexibility...
A recent rule proposed by the...
03/20/2017
First Report Managed Care
03/20/2017
In the wake of the recently blocked health insurance mega-mergers, experts predict what the big payers might target next.
In the wake of the recently blocked health insurance mega-mergers, experts predict what the big payers might target next.
In the wake of the recently...
03/20/2017
First Report Managed Care
Department
03/20/2017
According to data, longer-term utilization of Xolair (omalizumab; Genentech) produced positive responses in a larger number of patients than expected.
According to data, longer-term utilization of Xolair (omalizumab; Genentech) produced positive responses in a larger number of patients than expected.
According to data, longer-term...
03/20/2017
First Report Managed Care
Department
03/20/2017
Recent research presented at the 2017 AAAAI Annual Meeting revealed that while the majority of specialty guidelines contain recommendations that take costs into account, no standard methodology exists for approaching cost concerns during...
Recent research presented at the 2017 AAAAI Annual Meeting revealed that while the majority of specialty guidelines contain recommendations that take costs into account, no standard methodology exists for approaching cost concerns during...
Recent research presented at the...
03/20/2017
First Report Managed Care
Department
03/20/2017
According to real-world data, patients treated with Xolair (omalizumab; Genentech) experienced decreased asthma exacerbations and hospitalizations compared with baseline.
According to real-world data, patients treated with Xolair (omalizumab; Genentech) experienced decreased asthma exacerbations and hospitalizations compared with baseline.
According to real-world data,...
03/20/2017
First Report Managed Care
Department
03/20/2017
Uncontrolled asthma can have a significant impact on health care resource utilization and work productivity.
Uncontrolled asthma can have a significant impact on health care resource utilization and work productivity.
Uncontrolled asthma can have a...
03/20/2017
First Report Managed Care

News

News
03/20/2017
The opioid crisis has left payers struggling between effectively managing pain with prescription narcotics and withholding medication to prevent abuse and addiction.
The opioid crisis has left payers struggling between effectively managing pain with prescription narcotics and withholding medication to prevent abuse and addiction.
The opioid crisis has left...
03/20/2017
First Report Managed Care
News
03/20/2017
Implementation of the Asthma Adherence Pathway among treatment physicians helped to improve adherence to Dulera and improved asthma control.
Implementation of the Asthma Adherence Pathway among treatment physicians helped to improve adherence to Dulera and improved asthma control.
Implementation of the Asthma...
03/20/2017
First Report Managed Care

Advertisement

Advertisement

Advertisement